Why Bifidobacteria Matters More Than You May Think - Especially in Children With IBD

What you probably think about Bifidobacteria - and what's actually true

Most parents I work with have heard of bifidobacteria. It's the friendly gut bacteria, it's in yoghurt, babies are born with it. Familiar territory.

But in my clinical work, bifidobacteria is the finding that surprises families most - not because it's complicated, but because what they assumed about it turns out not to be the full picture. And that gap has real consequences for their child's health.

Let's work through some of those assumptions.

"Everyone has bifidobacteria. It's there from birth, right?"

Partly true, and that's why this one often sticks.

In healthy infants, particularly those breastfed by mothers with an active FUT2 gene (more on that shortly), bifidobacteria can make up more than 70% of all microbial cells in the gut. It's one of the very first colonisers, and in early life it dominates. It helps establish the immune system, trains the gut lining to tolerate rather than overreact, and lays down the microbial foundations supposed to serve your child for life.

That abundance naturally declines as children move to solid food. What isn't expected is for it to fall significantly further. In children with IBD, that's frequently what happens. Research has confirmed that both the abundance and diversity of bifidobacterial populations are significantly lower in children with IBD compared with healthy children.

Being born with it doesn't mean it stays. And in the children I test most often, it frequently hasn't.

"We eat well, so our bifido must be fine"

This is the assumption stool testing challenges most reliably.

Diet matters enormously for bifido. But several things can deplete it even when the diet looks good on paper.

The FUT2 gene. There's a gene called FUT2, the secretor gene, that directly shapes how well bifidobacteria establishes and thrives in the gut. It controls whether certain protective sugars are expressed in the gut's mucous lining, and those sugars are one of bifidobacteria's preferred fuel sources. People who carry non-functional variants of this gene, known as non-secretors, have significantly reduced bifidobacterial diversity, richness and abundance, regardless of what they eat. Roughly one in five people carry this variant. You won't know without testing.

Therapeutic diets. Many children with IBD go through periods on exclusive enteral nutrition (EEN), or need to restrict fibre during or after a flare when the gut is too inflamed to tolerate it. Others follow gluten-free or low-FODMAP approaches long-term. All of these, while sometimes necessary, can remove specific prebiotic substrates that bifidobacteria depends on. The diet can look varied and nutritious while the particular fuel bifido needs most is missing.

Without testing, you won't know which of these applies to your child. And you can't compensate for something you don't know is missing.

"My digestion is fine just now - bifido can't be an issue"

This is where it gets interesting. Low bifidobacteria often doesn't show up as a digestive symptom at all.

Think about the broader picture: immune resilience, skin reactivity, how well your child recovers from infections. These are all areas where bifidobacteria plays a role. And then there are the symptoms that tend to surprise people most.

Bifidobacteria contributes to the production of GABA, one of the brain's main calming chemicals, and influences serotonin pathways. Specific strains, particularly B. breve, have shown clinical evidence of easing low mood and sleep difficulties through their effects on tryptophan and serotonin metabolism. When bifido is low, the gut-brain communication involved in mood and sleep is affected.

Histamine is another piece of this. Most people associate it with hay fever, but it's a chemical messenger with a much broader reach - influencing gut motility, skin, sleep, wakefulness and mood. When the gut microbiome is disrupted, histamine can build up rather than being broken down efficiently. People with histamine sensitivity have been found to have lower Bifidobacteriaceae levels and signs of intestinal barrier dysfunction. Bifidobacterium longum specifically is associated with better histamine metabolism.

In practice, low bifido can look like persistent fatigue, mood that's hard to regulate, poor sleep, food or skin reactivity without a clear pattern, or brain fog. Often several of these together, with no obvious explanation.

I've seen first hand in clinic - a child with low bifido on testing despite an excellent diet. Once we addressed this, starting with prebiotic support and then targeted strains, mood settled, sleep improved and the reactivity calmed considerably. The gut was the thread connecting symptoms that could otherwise seem unrelated.

"We've been careful with antibiotics, so the gut should be fine"

Being thoughtful about antibiotic use matters. and of course, when they're needed, they're needed. This isn't about avoiding them when they're necessary. It's about understanding that antibiotic history is one piece of the bifido picture, not the whole of it.

Genetics can predispose a child to lower bifido from the start. Therapeutic diets remove key substrates. IBD itself creates a gut environment where bifido struggles.

Here's why that last point matters even in settled disease. Bifidobacteria works as part of a community - different species supporting and depending on each other. Research in Crohn's disease found that the breakdown of these cooperative relationships between gut organisms is more pronounced during remission than during active disease. Even when things look clinically stable, the microbial community can still be working well below where it should be.

Careful antibiotic use is a good start. It's not the whole story.

"My child is in remission - we're past this now"

Clinical remission is something to celebrate. But it isn't the same as microbiome recovery - and for IBD families, that distinction matters.

As the research above shows, the cooperative relationships between gut bacteria can remain disrupted even when symptoms have quietened and medication is doing its job. Bifidobacteria helps keep the immune system balanced, not just in the gut but more broadly. Research has found that lower bifidobacteria before a viral infection is linked to a greater chance of getting ill and experiencing more severe symptoms - and that improving bifidobacterium levels may reduce that risk. For children on immunosuppressive medication, where a virus can be enough to destabilise things, this is directly relevant.

Studies in Crohn's disease have found that bifidobacteria is only partially restored in patients who are in remission - partially, not fully. Medication manages the immune response. Rebuilding the microbiome is a separate job, and it doesn't happen on its own.

If you're in the middle of managing a flare right now, that is the priority. But your child's wider gut environment - how resilient it is, how well it recovers - is being shaped at the same time. Bifidobacteria is part of that, and supporting it is part of what may help protect against what comes next.

"Does bifido affect how well my child's medication works?"

It's something I look at closely in my own clinical work - and the research is starting to give us some useful answers.

The gut microbiome and IBD medications don't operate independently of each other. Research has found that the baseline composition of the gut microbiome differs between IBD patients who respond well to biologic therapy and those who don't. Studies have also found that B. longum can improve the efficacy of infliximab in colitis models, working through its effects on the gut environment and metabolic pathways.

This is still emerging research rather than established clinical guidance. But what is clear: the state of the microbiome isn't separate from how well treatment works. It's part of the same system - and one of the reasons microbiome support is so important in my practice.

"I can just take a probiotic"

This one explains why many families try probiotics, notice little difference, and conclude they don't work.

A probiotic with a long list of strains on the label isn't the same as a targeted clinical intervention. When bifido is low and the gut environment is disrupted, introducing organisms without first preparing the terrain often means they simply don't establish.

What I find in practice is that sequencing matters as much as the product itself. What you use, when, and in what order - all of this affects whether it actually works. Getting that right is something I work through carefully with every family, because the same supplement at the wrong time or without the right foundation can achieve very little, while the right approach for that child can shift things considerably.

"This is a gut health story. It's not really about long-term health"

When María Branyas Morera died in 2024 at the age of 117, researchers found her gut was as diverse as someone decades younger, and especially rich in Bifidobacteriaceae.

Her team linked those high levels to low inflammatory markers and strong short-chain fatty acid production. Studies of centenarians have found that Bifidobacterium species are significantly more prevalent in those aged 99 to 104 than in the general elderly population.

She ate yoghurt daily, kept a Mediterranean diet, and stayed active. Her bifido stayed strong into her 117th year.

For children with IBD, the long-term picture takes on a specific shape. Managing what's happening now is vital. But your child's gut environment, how resilient it is, how well it recovers, how equipped it is to handle the next challenge, is something being shaped right now. Bifidobacteria is part of that foundation.

So what does this mean for you?

You can't manage what you can't see.

Whether your child is in a flare or in remission. Whether they eat well or are on a restricted therapeutic diet. Whether their main symptoms are gut-related or showing up as fatigue, mood, skin or sleep. None of that tells you what their bifidobacteria looks like at species level. Only a stool test does.

For many families I work with, the test result is the moment things start to make sense. The symptom that hadn't fitted. The fatigue that wasn't explained. The mood that seemed separate from the IBD. Bifido is often part of that picture, and often the part nobody had looked at.

If you don't know your child's bifido status, it's worth finding out.

Stool and genetic testing is something I offer as part of my clinical work, with proper interpretation so you're not left without context. If you'd like to understand what's going on in your child's gut microbiome, you're welcome to book a call.

References/further reading

Maukonen et al. (2015) Altered fecal microbiota in paediatric IBD. J Crohns Colitis. PMID: 26351391

Wacklin et al. (2011) Secretor genotype (FUT2) and bifidobacteria composition. PLoS ONE. PMID: 21625510

Mastromarino et al. (2015) Maternal FUT2 status and infant bifidobacterial communities. Microbiome. PMID: 25905017

Hazan et al. (2022) Bifidobacterium depletion and COVID-19 severity. BMJ Open Gastroenterology. PMID: 35483774

Cao et al. (2024) Gut virome disturbance in Crohn's disease. Nature Communications. PMID: 38326291

Schink et al. (2018) Microbial patterns in histamine intolerance. J Physiology & Pharmacology. PMID: 30683819

Skonieczna-Żydecka et al. (2025) Psychobiotics in depression. Nutrients. PMID: 40564183

Hsieh et al. (2024) Bifidobacterium, longevity and centenarians. Frontiers in Microbiology. PMID: 39175784

Zhang et al. (2022) Gut microbiota and biological therapy in IBD. Frontiers in Immunology. PMID: 35734159